← FDA DRUG APPROVALS

FDA ANDA · ANDA084506

DIPHENHYDRAMINE HYDROCHLORIDE

Sponsor: MUTUAL PHARM

APPLICATION
ANDA084506
TYPE
ANDA
ORIGINAL APPROVAL
1974-12-19
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DIPHENHYDRAMINE HYDROCHLORIDEDiscontinued
DIPHENHYDRAMINE HYDROCHLORIDE 25MG · CAPSULE · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 58AP
1994-12-23Manufacturing (CMC) · Supplement 57AP
1994-10-11Manufacturing (CMC) · Supplement 56AP
1992-04-03Manufacturing (CMC) · Supplement 55AP
1992-04-03Manufacturing (CMC) · Supplement 53AP
1988-04-21Labeling · Supplement 52AP
1987-03-20Manufacturing (CMC) · Supplement 50AP
1986-02-11Manufacturing (CMC) · Supplement 48AP
1986-02-11Manufacturing (CMC) · Supplement 47AP
1983-03-31Manufacturing (CMC) · Supplement 41AP
1974-12-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →